Cargando…
Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts
Mycobacterium tuberculosis (M.tb) is likely the most successful human pathogen, capable of evading protective host immune responses and driving metabolic changes to support its own survival and growth. Ineffective innate and adaptive immune responses inhibit effective clearance of the bacteria from...
Autores principales: | Kotzé, Leigh A., Young, Carly, Leukes, Vinzeigh N., John, Vini, Fang, Zhuo, Walzl, Gerhard, Lutz, Manfred B., du Plessis, Nelita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047144/ https://www.ncbi.nlm.nih.gov/pubmed/32113158 http://dx.doi.org/10.1016/j.ebiom.2020.102670 |
Ejemplares similares
-
Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
por: du Plessis, Nelita, et al.
Publicado: (2018) -
Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020) -
Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells
por: John, Vini, et al.
Publicado: (2019) -
Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
por: Leukes, Vinzeigh N., et al.
Publicado: (2022) -
Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis
por: Leukes, Vinzeigh N., et al.
Publicado: (2021)